← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Revenue increased 6.9% to $1.55B, while Net income increased 31.7% to $527.5M.
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue $1.55BOK
- Profitability — Net income $527.5MOK
- Cash generation — Free cash flow N/ANote
- Accounting — No applicable forensic screenNote
- Insiders — 0 buys; 7 sells in 365 daysNote
- Capital — dividends paid were $511.6M; share repurchases were $200.1MNote
Business
REGENCY CENTERS CORP: We expect to meet these needs by using a combination of the following: cash flows from operations after funding our common stock and preferred stock dividends, borrowings from our Line, proceeds from the sale of real estate, mortgage loan and unsecured bank financing, distributions received from our real estate partnerships, and when the capital markets are favorable, proceeds from the sale of equity securities or the issuance of new unsecured debt.
Where the revenue comes from
Fiscal 2025, as REGENCY CENTERS CORP reports it. History and quarterly detail are in the app.
Leadership changes
From REGENCY CENTERS CORP's own filings, the day they're filed.
- Leasing Agent · President · appointment
- C. Ronald Blankenship · Directors · departure
Latest filings
- 8-K · Company announcement2026-08-11
- 8-K · Company announcement2026-08-06
- 10-Q · Quarterly report2026-08-03
- 8-K · Company announcement2026-07-29
- 8-K · Company announcement2026-06-01
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about REGENCY CENTERS CORP, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.